Exploiting KRAS-mediated metabolic reprogramming as a therapeutic target.

Bootsma, Sanne; van Neerven, Sanne M; Vermeulen, Louis

Bootsma, Sanne; van Neerven, Sanne M; Vermeulen, Louis.

Afiliação

Bootsma S; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
van Neerven SM; Oncode Institute Amsterdam, Amsterdam, the Netherlands.
Vermeulen L; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, Amsterdam, the Netherlands.

Nat Genet ; 53(1): 9-10, 2021 01.

Article em En | MEDLINE | ID: mdl-33414546

Assuntos

Neoplasias do Colo; Neoplasias Colorretais; Humanos; Transportador 1 de Aminoácidos Neutros Grandes; Proteínas Proto-Oncogênicas p21(ras)/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias do Colo Limite: Humans Idioma: En Revista: Nat Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google